vs
Side-by-side financial comparison of Krispy Kreme, Inc. (DNUT) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $392.4M, roughly 1.3× Krispy Kreme, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -7.1%, a 13.9% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -2.9%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -5.9%).
Krispy Kreme, Inc. is an American multinational doughnut company and coffeehouse chain. Krispy Kreme was founded by Vernon Rudolph (1915–1973), who bought a yeast-raised recipe from a New Orleans chef, rented a building in 1937 in what is now historic Old Salem in Winston-Salem, North Carolina, and began selling to local grocery stores. Steady growth preceded an ambitious expansion as a public company in the period 2000 to 2016, which ultimately proved unprofitable. In 2016, the company retur...
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
DNUT vs MD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $392.4M | $493.8M |
| Net Profit | $-27.8M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | -1.9% | 9.9% |
| Net Margin | -7.1% | 6.8% |
| Revenue YoY | -2.9% | -1.7% |
| Net Profit YoY | -23.8% | 10.5% |
| EPS (diluted) | $-0.18 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $392.4M | $493.8M | ||
| Q3 25 | $375.3M | $492.9M | ||
| Q2 25 | $379.8M | $468.8M | ||
| Q1 25 | $375.2M | $458.4M | ||
| Q4 24 | $404.0M | $502.4M | ||
| Q3 24 | $379.9M | $511.2M | ||
| Q2 24 | $438.8M | $504.3M | ||
| Q1 24 | $442.7M | $495.1M |
| Q4 25 | $-27.8M | $33.7M | ||
| Q3 25 | $-19.4M | $71.7M | ||
| Q2 25 | $-435.3M | $39.3M | ||
| Q1 25 | $-33.3M | $20.7M | ||
| Q4 24 | $-22.4M | $30.5M | ||
| Q3 24 | $39.6M | $19.4M | ||
| Q2 24 | $-5.5M | $-153.0M | ||
| Q1 24 | $-8.5M | $4.0M |
| Q4 25 | -1.9% | 9.9% | ||
| Q3 25 | -1.9% | 13.8% | ||
| Q2 25 | -114.4% | 12.8% | ||
| Q1 25 | -5.4% | 7.0% | ||
| Q4 24 | -2.8% | 7.8% | ||
| Q3 24 | -4.2% | 6.6% | ||
| Q2 24 | 1.6% | -31.3% | ||
| Q1 24 | 2.7% | 3.2% |
| Q4 25 | -7.1% | 6.8% | ||
| Q3 25 | -5.2% | 14.5% | ||
| Q2 25 | -114.6% | 8.4% | ||
| Q1 25 | -8.9% | 4.5% | ||
| Q4 24 | -5.6% | 6.1% | ||
| Q3 24 | 10.4% | 3.8% | ||
| Q2 24 | -1.3% | -30.3% | ||
| Q1 24 | -1.9% | 0.8% |
| Q4 25 | $-0.18 | $0.40 | ||
| Q3 25 | $-0.11 | $0.84 | ||
| Q2 25 | $-2.55 | $0.46 | ||
| Q1 25 | $-0.20 | $0.24 | ||
| Q4 24 | $-0.13 | $0.37 | ||
| Q3 24 | $0.23 | $0.23 | ||
| Q2 24 | $-0.03 | $-1.84 | ||
| Q1 24 | $-0.05 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $42.4M | $375.2M |
| Total DebtLower is stronger | $911.9M | $570.5M |
| Stockholders' EquityBook value | $650.1M | $865.9M |
| Total Assets | $2.6B | $2.2B |
| Debt / EquityLower = less leverage | 1.40× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $42.4M | $375.2M | ||
| Q3 25 | $30.7M | $340.1M | ||
| Q2 25 | $21.3M | $224.7M | ||
| Q1 25 | $18.7M | $99.0M | ||
| Q4 24 | $29.0M | $229.9M | ||
| Q3 24 | $25.4M | $103.8M | ||
| Q2 24 | $28.6M | $19.4M | ||
| Q1 24 | $33.1M | $8.0M |
| Q4 25 | $911.9M | $570.5M | ||
| Q3 25 | $906.2M | $577.2M | ||
| Q2 25 | $889.4M | $583.9M | ||
| Q1 25 | $935.0M | $590.5M | ||
| Q4 24 | $844.5M | $597.1M | ||
| Q3 24 | $804.6M | — | ||
| Q2 24 | $895.0M | — | ||
| Q1 24 | $881.8M | — |
| Q4 25 | $650.1M | $865.9M | ||
| Q3 25 | $670.3M | $890.7M | ||
| Q2 25 | $693.6M | $833.8M | ||
| Q1 25 | $1.1B | $789.2M | ||
| Q4 24 | $1.1B | $764.9M | ||
| Q3 24 | $1.2B | $732.5M | ||
| Q2 24 | $1.1B | $706.5M | ||
| Q1 24 | $1.2B | $856.2M |
| Q4 25 | $2.6B | $2.2B | ||
| Q3 25 | $2.6B | $2.2B | ||
| Q2 25 | $2.6B | $2.1B | ||
| Q1 25 | $3.1B | $2.0B | ||
| Q4 24 | $3.1B | $2.2B | ||
| Q3 24 | $3.1B | $2.1B | ||
| Q2 24 | $3.2B | $2.0B | ||
| Q1 24 | $3.2B | $2.2B |
| Q4 25 | 1.40× | 0.66× | ||
| Q3 25 | 1.35× | 0.65× | ||
| Q2 25 | 1.28× | 0.70× | ||
| Q1 25 | 0.85× | 0.75× | ||
| Q4 24 | 0.74× | 0.78× | ||
| Q3 24 | 0.68× | — | ||
| Q2 24 | 0.79× | — | ||
| Q1 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.0M | $114.1M |
| Free Cash FlowOCF − Capex | $27.9M | — |
| FCF MarginFCF / Revenue | 7.1% | — |
| Capex IntensityCapex / Revenue | 4.4% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $-64.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.0M | $114.1M | ||
| Q3 25 | $42.3M | $137.3M | ||
| Q2 25 | $-32.5M | $137.2M | ||
| Q1 25 | $-20.8M | $-117.5M | ||
| Q4 24 | $27.0M | $133.0M | ||
| Q3 24 | $3.3M | $91.8M | ||
| Q2 24 | $33.2M | $107.0M | ||
| Q1 24 | $-17.7M | $-125.2M |
| Q4 25 | $27.9M | — | ||
| Q3 25 | $15.5M | — | ||
| Q2 25 | $-60.8M | — | ||
| Q1 25 | $-46.7M | — | ||
| Q4 24 | $-6.9M | — | ||
| Q3 24 | $-22.9M | — | ||
| Q2 24 | $1.6M | — | ||
| Q1 24 | $-46.8M | — |
| Q4 25 | 7.1% | — | ||
| Q3 25 | 4.1% | — | ||
| Q2 25 | -16.0% | — | ||
| Q1 25 | -12.5% | — | ||
| Q4 24 | -1.7% | — | ||
| Q3 24 | -6.0% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | -10.6% | — |
| Q4 25 | 4.4% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 7.4% | — | ||
| Q1 25 | 6.9% | — | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 6.9% | — | ||
| Q2 24 | 7.2% | — | ||
| Q1 24 | 6.6% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | — | -5.66× | ||
| Q4 24 | — | 4.36× | ||
| Q3 24 | 0.08× | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DNUT
Segment breakdown not available.
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
